Form EFFECT CERO THERAPEUTICS HOLDIN
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- What XRP Price Prediction Reveals as Apeing Enters the Market With a Live $0.0001 Presale in the Search for the Next Crypto to Explode
- Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 08 09 2026] - (CGWL)
- Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share